Table.
Comparison between starters and non-starters of medication (pre-treatment attrition) and between those who discontinued and continued the medication
| Pre-treatment attrition (n=35) | ||
|---|---|---|
| Parameters | Mean±SD/frequency | |
| Non-starters (n=8) | Starters (n=27) | |
| Age (yr) | 9.62±3.58 | 10.29±3.75 |
| Gender (male), n (%) | 8 (100) | 23 (85.2) |
| IQ | 92.12±13.26 | 81.89±19.61 |
| Presence of ID | 1 (12.5) | 7 (26) |
| Baseline symptom severity | 35.16±7.18 | 38.07±9.15 |
| Presence of comorbidity | 1 (12.5) | 10 (37.03) |
| Family type (joint) | 7 (87.5) | 9 (33.34)** |
| Discontinuation among those who started medication (n=27) | ||
| Parameters | Mean±SD/frequency | |
| Discontinuers (n=12) | Continuers (at the end of study) (n=15) | |
| Age (yr) | 10.00±2.92 | 10.53±2.69 |
| Gender (male), n (%) | 10 (83.34) | 13 (86.67) |
| IQ | 74.92±19.13 | 87.60±18.60 |
| Presence of ID | 6 (50) | 1 (6.67)* |
| Baseline symptom severity | 36.42±8.13 | 39.40±9.97 |
| Presence of comorbidity | 4 (33.34) | 6 (40) |
| Presence of ASD | 3 (25) | 0 (0) |
| Presence of severe side effects | 4 (33.34) | 0 (0)* |
| Family type (joint) | 4 (33.34) | 5 (33.34) |
Values in parentheses are percentages. P*<0.05, **<0.01 compared to respective group. ID, intellectual disability; IQ, intellectual quotient; ASD, autism spectrum disorder